F
Frank M. Sacks
Researcher at Harvard University
Publications - 520
Citations - 86842
Frank M. Sacks is an academic researcher from Harvard University. The author has contributed to research in topics: Cholesterol & Weight loss. The author has an hindex of 120, co-authored 490 publications receiving 80422 citations. Previous affiliations of Frank M. Sacks include Erasmus University Rotterdam & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
The influence of apolipoprotein E on the interactions between normal human very low density lipoproteins and U937 human macrophages: heterogeneity among persons.
TL;DR: In this article, the extent to which apo E is involved in the cell binding and uptake of VLDL from different normolipidemic persons is not well defined.
Journal ArticleDOI
Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans
Nirav K. Desai,Nirav K. Desai,Esther M.M. Ooi,Esther M.M. Ooi,Paul Mitchell,Jeremy D. Furtado,Frank M. Sacks +6 more
TL;DR: VLDL with apoA-II represents a small pool of VLDL particles that has a slow FCR and is predominantly converted to IDL rather than cleared from the circulation.
Journal ArticleDOI
[The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome].
Jesús Millán Núñez-Cortés,Juan Pedro-Botet Montoya,Xavier Pintó Salas,Antonio Hernández Mijares,Vincent J. Carey,Michel P. Hermans,Frank M. Sacks,Jean-Charles Fruchart +7 more
TL;DR: The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment.
Journal ArticleDOI
Prospective pravastatin pooling project: Relative risk reduction by baseline HDL and TG concentrations
Frank M. Sacks,Andrew Tonkin,J. Shepherd,Eugene Braunwald,S. M. Cobbe,M Hawkins,Anthony C Keech,Christopher J. Packard,John Simes,Robert P. Byington,C. D. Furberg +10 more
Journal ArticleDOI
JCL roundtable: Apolipoproteins as causative elements in vascular disease
TL;DR: The number of particles containing apolipoprotein B (apoB) can be abnormally high with a value for low-density lipoprotein cholesterol, which is within the authors' guidelines, and the content of apoC3 in apoB-containing lipoproteins can predict risk without a close association with triglycerides or cholesterol.